Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009

Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]


Sanofi to Present More Acomplia Data at April 11th Meeting

Sanofi-Aventis, developer of the highly publicized anti–obesity drug Acomplia, will present new data on the drug’s role in reducing metabolic cardiovascular disease risk factors at a scientific meeting in San Diego April 11th and 12th.
Dr. Pierre Rosenzweig, a Vice President of Sanofi-Aventis, will make the presentation at the Annual Metabolic [...]


Report in The Lancet Further Boosts Interest in Weight-Loss Drug Acomplia

A report published in this week’s issue of the prestigious medical journal, The Lancet, further stoked interest in the promising new weight-loss drug Acomplia (rimonabant)  but in fact provided little new information.
The report was based on one-year results from the RIO–Europe clinical trial, which [...]


Diet Pills: The Future

Diet Pills: The Future’
The quest for the perfect weight loss drug continues as the prevalence of obesity in the United States and other industrialized
countries rises.Why has it been so difficult for drug manufacturers to develop the “perfect” diet pill? One reason is that the causes of obesity are not [...]


Support for “Metabolic Syndrome” May Buttress Expanded Role for Acomplia

The American Heart Association (AHA) and the National Heart, Lung and Blood Institute (NHLBI) on Sept. 13 issued a new scientific statement taking issue with two major diabetes organizations Acomplia (rimonabant)  that a month ago questioned the validity of diagnosing patients with “metabolic syndrome.”
The debate could well impact efforts of [...]


Dietary Supplements stimulants for Weight Loss

Dietary Supplements stimulants for Weight Loss
With the withdrawal of ephedra from the U.S. market, companies producing dietary supplements for weight loss have replaced ephedra with other stimulants to induce weight loss. Many of these stimulants contain caffeine or are very similar to caffeine. Caffeine and related substances suppress appetite and cause increased [...]


Diet Pill Acomplia Now Widely Available in Mexican Border Pharmacies

Diet drug Acomplia (rimonabant) , which seems at best months away from sale in the United States, is now widely available in pharmacies just across the Mexican border.
Readers increasingly are sending us reports on their experiences purchasing the highly anticipated diet pill in Mexican towns just across [...]


Drugs and Hormones

Drugs and Hormones
Several drugs and hormones have an effect on body weight. Some hormones cause weight gain and others cause weight loss. Hormones that cause weight gain are of particular interest, because if researchers can study and understand how they work, they may be able to develop drugs that can [...]


News Acomplia Zimulti